Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$153.62
-1.20-0.78%
At close: Nov 18, 4:00 PM EST
$153.55
-0.07-0.05%
After Hours: 7:43 PM EST
Comments
Loading...
Chevron Analyst Ratings and Price Targets | NYSE:CVX | Benzinga
Chevron Corp has a consensus price target of $172.91 based on the ratings of 25 analysts. The high is $204 issued by Mizuho on November 13, 2025. The low is $124 issued by Redburn Atlantic on April 23, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, Piper Sandler, and Mizuho on November 14, 2025, November 13, 2025, and November 13, 2025, respectively. With an average price target of $189.33 between Wells Fargo, Piper Sandler, and Mizuho, there's an implied 23.30% upside for Chevron Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Piper Sandler
Mizuho
Morgan Stanley
Raymond James
1calculated from analyst ratings
Analyst Ratings for Chevron
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/14/2025 | 27.65% | Wells Fargo | $190 → $196 | Maintains | Overweight | |||
11/13/2025 | 9.41% | Piper Sandler | $169 → $168 | Maintains | Overweight | |||
11/13/2025 | 32.86% | Mizuho | $191 → $204 | Maintains | Outperform | |||
11/13/2025 | 17.23% | Morgan Stanley | $177 → $180 | Maintains | Overweight | |||
11/10/2025 | 10.06% | Piper Sandler | $171 → $169 | Maintains | Overweight | |||
11/03/2025 | 15.27% | Morgan Stanley | $174 → $177 | Maintains | Overweight | |||
10/17/2025 | 4.2% | Raymond James | $170 → $160 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 23.74% | Wells Fargo | → $190 | Initiates | → Overweight | |||
10/09/2025 | 7.46% | Scotiabank | $160 → $165 | Maintains | Sector Perform | |||
10/07/2025 | 2.9% | Barclays | $160 → $158 | Maintains | Equal-Weight | |||
09/15/2025 | 24.39% | Mizuho | $192 → $191 | Maintains | Outperform | |||
09/10/2025 | 20.48% | B of A Securities | $170 → $185 | Maintains | Buy | |||
08/20/2025 | 28.3% | UBS | $186 → $197 | Maintains | Buy | |||
08/20/2025 | 0.94% | Melius Research | → $155 | Initiates | → Hold | |||
08/18/2025 | 9.41% | Piper Sandler | $164 → $168 | Maintains | Overweight | |||
08/13/2025 | 25.04% | Mizuho | $186 → $192 | Maintains | Outperform | |||
08/04/2025 | 21.13% | UBS | $177 → $186 | Maintains | Buy | |||
07/31/2025 | 17.23% | Evercore ISI Group | → $180 | Reinstates | → Outperform | |||
07/23/2025 | 15.92% | Wells Fargo | $165 → $178 | Maintains | Overweight | |||
07/11/2025 | 4.2% | Scotiabank | $143 → $160 | Maintains | Sector Perform | |||
07/07/2025 | 1.6% | Barclays | $152 → $156 | Maintains | Equal-Weight | |||
07/02/2025 | 6.81% | Piper Sandler | $162 → $164 | Maintains | Overweight | |||
06/26/2025 | 7.46% | Wells Fargo | $164 → $165 | Maintains | Overweight | |||
05/13/2025 | 5.5% | Piper Sandler | $173 → $162 | Maintains | Overweight | |||
05/13/2025 | 2.9% | HSBC | $176 → $158 | Downgrade | Buy → Hold | |||
05/13/2025 | 21.13% | Mizuho | $188 → $186 | Maintains | Outperform | |||
05/05/2025 | 6.81% | Wells Fargo | $173 → $164 | Maintains | Overweight | |||
04/23/2025 | -19.24% | Redburn Atlantic | $156 → $124 | Downgrade | Neutral → Sell | |||
04/23/2025 | -1.01% | Barclays | $171 → $152 | Downgrade | Overweight → Equal-Weight | |||
04/15/2025 | 22.44% | Mizuho | $203 → $188 | Maintains | Outperform | |||
04/15/2025 | 12.67% | Wells Fargo | $184 → $173 | Maintains | Overweight | |||
04/11/2025 | -6.87% | Scotiabank | $160 → $143 | Downgrade | Sector Outperform → Sector Perform | |||
04/07/2025 | 20.48% | UBS | $194 → $185 | Maintains | Buy | |||
02/05/2025 | 32.2% | Mizuho | $194 → $203 | Maintains | Outperform | |||
02/05/2025 | 11.36% | Barclays | $174 → $171 | Maintains | Overweight | |||
02/04/2025 | 4.2% | Truist Securities | $164 → $160 | Maintains | Hold | |||
02/03/2025 | 26.34% | UBS | $195 → $194 | Maintains | Buy | |||
02/03/2025 | 13.97% | RBC Capital | $175 → $175 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 19.83% | Wells Fargo | $188 → $184 | Maintains | Overweight | |||
02/03/2025 | 13.97% | Raymond James | $180 → $175 | Maintains | Outperform | |||
01/17/2025 | 17.23% | Raymond James | $175 → $180 | Maintains | Outperform | |||
01/13/2025 | 6.81% | Truist Securities | $160 → $164 | Maintains | Hold | |||
12/19/2024 | 12.67% | Piper Sandler | $184 → $173 | Maintains | Overweight | |||
12/09/2024 | 22.44% | Wells Fargo | $171 → $188 | Maintains | Overweight | |||
12/06/2024 | 4.2% | Truist Securities | $155 → $160 | Maintains | Hold | |||
12/03/2024 | 26.99% | UBS | $194 → $195 | Maintains | Buy | |||
11/26/2024 | 20.48% | Citigroup | $145 → $185 | Upgrade | Neutral → Buy | |||
11/07/2024 | 26.34% | Mizuho | $189 → $194 | Maintains | Outperform | |||
11/04/2024 | 26.34% | UBS | $192 → $194 | Maintains | Buy | |||
11/04/2024 | 13.97% | RBC Capital | $170 → $175 | Maintains | Outperform | |||
11/04/2024 | 0.94% | Truist Securities | $150 → $155 | Maintains | Hold | |||
11/04/2024 | 13.32% | Barclays | $168 → $174 | Maintains | Overweight | |||
10/17/2024 | 9.41% | B of A Securities | → $168 | Reinstates | → Buy | |||
10/10/2024 | 6.15% | Scotiabank | $180 → $163 | Maintains | Sector Outperform | |||
10/08/2024 | 25.04% | UBS | $189 → $192 | Maintains | Buy | |||
10/08/2024 | 10.71% | RBC Capital | $170 → $170 | Reiterates | Outperform → Outperform | |||
10/03/2024 | 9.41% | Barclays | $185 → $168 | Maintains | Overweight | |||
09/30/2024 | -2.31% | Truist Securities | $154 → $150 | Maintains | Hold | |||
09/27/2024 | 10.06% | Wells Fargo | $196 → $169 | Maintains | Overweight | |||
09/18/2024 | 23.09% | UBS | $192 → $189 | Maintains | Buy | |||
09/16/2024 | 23.09% | Mizuho | $205 → $189 | Maintains | Outperform | |||
08/06/2024 | 20.48% | Barclays | $203 → $185 | Maintains | Overweight | |||
08/05/2024 | 17.23% | RBC Capital | $190 → $180 | Maintains | Outperform | |||
08/05/2024 | 0.29% | Truist Securities | $156 → $154 | Maintains | Hold | |||
07/22/2024 | 1.6% | Truist Securities | $166 → $156 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/17/2024 | 8.76% | Bernstein | $183 → $167 | Downgrade | Outperform → Market Perform | |||
07/12/2024 | 17.23% | Scotiabank | $195 → $180 | Maintains | Sector Outperform | |||
05/13/2024 | 33.51% | Mizuho | $200 → $205 | Maintains | Buy | |||
05/10/2024 | 8.11% | Truist Securities | $156 → $166 | Maintains | Hold | |||
04/30/2024 | 15.92% | HSBC | $175 → $178 | Maintains | Buy | |||
04/30/2024 | 34.16% | Wells Fargo | $198 → $206 | Maintains | Overweight | |||
04/29/2024 | 4.2% | TD Cowen | $155 → $160 | Maintains | Hold | |||
04/18/2024 | 32.86% | Piper Sandler | $180 → $204 | Maintains | Overweight | |||
04/15/2024 | 13.32% | Raymond James | $170 → $174 | Maintains | Outperform | |||
04/11/2024 | 26.99% | Scotiabank | $170 → $195 | Upgrade | Sector Perform → Sector Outperform | |||
04/10/2024 | 32.2% | Barclays | → $203 | Initiates | → Overweight | |||
04/09/2024 | 28.3% | UBS | $185 → $197 | Maintains | Buy | |||
04/05/2024 | 1.6% | Truist Securities | $168 → $156 | Maintains | Hold | |||
04/04/2024 | 28.95% | Wells Fargo | $185 → $198 | Maintains | Overweight | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
03/20/2024 | 30.25% | Mizuho | $195 → $200 | Maintains | Buy | |||
03/14/2024 | 17.23% | Piper Sandler | $188 → $180 | Maintains | Overweight | |||
02/06/2024 | 4.2% | DZ Bank | → $160 | Downgrade | Buy → Hold | |||
02/05/2024 | 23.74% | RBC Capital | $185 → $190 | Maintains | Outperform | |||
01/23/2024 | -2.31% | TD Cowen | $170 → $150 | Downgrade | Outperform → Market Perform | |||
01/16/2024 | 10.71% | Scotiabank | → $170 | Downgrade | Sector Outperform → Sector Perform | |||
01/08/2024 | 19.83% | Jefferies | → $184 | Upgrade | Hold → Buy | |||
12/14/2023 | 20.48% | UBS | $194 → $185 | Maintains | Buy | |||
11/14/2023 | 26.99% | Mizuho | $215 → $195 | Maintains | Buy | |||
11/02/2023 | 18.53% | Bernstein | $184 → $182 | Upgrade | Market Perform → Outperform | |||
10/30/2023 | 30.25% | B of A Securities | $190 → $200 | Upgrade | Neutral → Buy | |||
10/30/2023 | 13.97% | Raymond James | $200 → $175 | Maintains | Outperform | |||
10/24/2023 | 10.06% | Truist Securities | $175 → $169 | Maintains | Hold | |||
10/24/2023 | 17.23% | RBC Capital | → $180 | Reiterates | Outperform → Outperform | |||
10/17/2023 | 30.9% | Morgan Stanley | $203 → $201 | Maintains | Equal-Weight | |||
10/17/2023 | 19.83% | Bernstein | → $184 | Initiates | → Market Perform | |||
10/04/2023 | 36.76% | UBS | $209 → $210 | Maintains | Buy | |||
10/02/2023 | 32.2% | Morgan Stanley | $198 → $203 | Maintains | Equal-Weight | |||
09/18/2023 | 40.02% | Mizuho | $209 → $215 | Maintains | Buy |
FAQ
What is the target price for Chevron (CVX) stock?
The latest price target for Chevron (NYSE:CVX) was reported by Wells Fargo on November 14, 2025. The analyst firm set a price target for $196.00 expecting CVX to rise to within 12 months (a possible 27.65% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Chevron (CVX)?
The latest analyst rating for Chevron (NYSE:CVX) was provided by Wells Fargo, and Chevron maintained their overweight rating.
When was the last upgrade for Chevron (CVX)?
The last upgrade for Chevron Corp happened on November 26, 2024 when Citigroup raised their price target to $185. Citigroup previously had a neutral for Chevron Corp.
When was the last downgrade for Chevron (CVX)?
The last downgrade for Chevron Corp happened on May 13, 2025 when HSBC changed their price target from $176 to $158 for Chevron Corp.
When is the next analyst rating going to be posted or updated for Chevron (CVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chevron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chevron was filed on November 14, 2025 so you should expect the next rating to be made available sometime around November 14, 2026.
Is the Analyst Rating Chevron (CVX) correct?
While ratings are subjective and will change, the latest Chevron (CVX) rating was a maintained with a price target of $190.00 to $196.00. The current price Chevron (CVX) is trading at is $153.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
